Nr.14 - Ion Mereuta

Revistă ştiinţifico-practică
Pihut Oxana
METODE CONTEMPORANE ÎN DIAGNOSTICUL ȘI TRATAMENTUL BOLNAVILOR
CU METASTAZE DE TUMORI MALIGNE FĂRĂ FOCAR PRIMAR DEPISTAT
7. Anbari K.K., Schunter L.M., Buky L.P. et al. Melanoma of
unknown primary site: presentation, treatment and prognosis – a
single institution study. University of Pennsylvania Pigmented Lesion
Study Group. Cancer. 1997 May 1 79:9 p.1816-1821.
8. Armstrong A.S., Blackhall F.H. Management of cancer from
an unknown primary.// Expert Opin Pharmacother. 2007 Mac., 8(4),
p.445-455 (Review).
9. Ashicari R, Rosen P.P. et al. Breast cancer presenting as
axillary mass// Ann. Surg.-1976. N9.- p.415-417.
10. Baier M. Application fur tumormarker.//
Mitt.Dtsch.Klin.Chem.-1989.-V.20,#2.-p.54-57.
11. Barlogie B., Drewinko B., Schumann J. et al. Cellular
DNA content as a marker of neoplasia in a man.-Amer. J.Med.,
1980,N69,195-203.
12. Baron P.L., Gandara I. Et al. Bony metastases as the first
manifestation of a tumor.//Int. Ortop..-1991.-V.15N4.-p.373-376.
13. Baron P.L., Moore M.P. et al. Occult breast cancer
presenting with axillary metastasis.//Arch.Surg.-1990.-V.125,#2.-
p.210-214.
14. Bates S. E. Clinical applications of serum tumor markers./
/Ann.Int.Med.-1991.-V.115,N8.-p.623-638.
15. Bates S. E. The use and potential of serum tumor markers,
new and old.//Drugs.-1989.-V.38,N1.-p.9-18.
16. Bernal M.P., Cazar E.L., Estevez R.A., Uboldi J.R. Tumor
primitivo disconocido// Rev. Latinoamer. oncol. clin.-1988.-v.20,
35.-p.5-19.
17. Braud F., Sarraf M. Diagnosis and management of
squamots cell carcinoma of unknown primary tumor site of the
neck.//Sem.Oncol.-1993.-v.20,31.-p.273-278.
18. Bittner H., Rosanowski F., Pottek T. Et al. Metastases of
germ cell tumors to the ENT area – a rare differential diagnosis of
lymph node metastases in unknown primary tumor.
Laryngorhinootologie. 1996 Oct. 75:10 p.616-618.
19. Bordel Gomez M.T., Used Aznar M.M. Cutaneous
metastases from adenocarcinoma of unknown primary site. Actas
Dermosifiliogr., 2006 Dec; 97(10): 662-665.
20. Brown R.W., Campagna L.B., Dunn J.K. et al.
Immunohistochemical identification of tumor markers in metastatic
adenocarcinoma . A diagnostic adjunct in the determination of
primary site. Am.J.Clin. Pathol. 1997 Jan.107:1 p.9-12.
21. Cardano S., Cornaglia G., Monteverde A.I. A worrisome
scintigraphy. Recenti Prog. Med. 2006 Jul-August; 97(7-8): 393-396.
22. CastiatoD.A.,Chapter 103, Metastasis of unknown origin.
In Haskell, C.M.(ed). Cancer treatment (4 th ed.)Philadelphia: W.B.
Saunders,1994.
23. Castiato D.A., Lowitz B.B. Manual of Clinical
Oncology.(Third edition) Boston- New York-Toronto-
London,1995,625p.
24. Chee C.P. Brain metastasis of unknown origin.//
Sing.Med.J.- 1990.- V.31,32.-p.48-50.
25. Chevalier T.L., Cvitcovic E., Caille P., Harvey J., Contesso
G., Spielmann M., Rouesse J. Early metastatic cancer of unknown
primary origin presentation. A clinical study of 302 consecutive
autopsied patients. Arch. Intern. Med.1988,V.148, p.2035-2039.
26. Cohen A.D., Neuman A., Cohen Y. Serum tumor markers
in the diagnosis of cancer of unknown primary site. Harefuah,
1995, Oct., 129:7-8h.279-282.
27. Daugaard G. Unknown primary tumours.//Can.Treat.Rev.-
1994.-V.20.-p.119-147.
28. De Santo L.W., Neel H.B. Squamous cell carcinoma:
metastasis to the neck from unknown or undiscovered primary.//
Otolaryng.Clin.N.A.-1985.-V.18,N3.-p.505-513.
29. Destombe C., Botton E., Le Gal G., Roudant A., Jousse
Joulin S., Devanchelle-Pensec V., Saranx A. Investigations for
bone metastasis from an unknown primary. Joint Bone Spine. 2007
Jan; 74(1): 85-89.
30. De Vit R., Hoek F.J., Bakker P.R., Veenho C.H. The value
of MCA, CA 15-3, CEA and CA-125 for discrimination between
metastatic breast cancer and adenocarcinoma of other primary
sites.//J.Int.Med.-1991.-V.229,#5.-p.463-466.
31. Ellerbroek N., Holmes F. Et al. Treatment of patients with
isolated axillary nodal metastases from an occult primary
carcinoma consistent with breast origin.// Cancer.-1990.-V.66,#7.-
p.1461-1467.
32. Farag S.S. et al. Delay by internists in obtaining diagnostic
biopsies in patients with suspected cancer. Ann. Intern. Med.
116:473, 1992.
33. Feienmesser R., Feienmesser M. et al. Detection of occult
nasopharyngeal primary tumors by means of in situ hybridization./
/J. Laryngol/Otol.-1992.-V.106,#4.- p.345-348.
34. Feun L.G, Savarag N. Detection of occult bone metastasis
by MRI scan.//J.Fl.Med.Assoc.-1990.-V.77, N10.-p.881-883.
35. Font W.F., Cordies J.N., Diaz S.C., Solano L.P. Sistematica
diagnostica frente a una metastasis sin tumor primario conocido./
/Rev.cub.oncol.-1989.-v.5,#1-2.-p.9-15.
36. Frost P., Raber M., Ambbrtzzese J.L. Unknown primary
tumors as a unique clinical and biologic entity a hypothesis. Cancer
Bull., 1989, 41-3,p.139-141.
37. Gambardella G., Santamaria L.B et al. Brain metastases:
surgical versus conservative treatment. //J. Neurosurg.-1990.-
v.34,#3-4.-p.309-314.
38. Gamble A.R, Bell J. A. et al. Use of tumour marker
immunoreactivity to identify primary site of metastatic cancer.//
B.M.J.-1993.-V.306, N1.-p.295-298.
39. Gatter K, Alcock C, Heryet A, Mason D. Clinical
importance of analysing malignant tumors of uncertain origin with
immunogistological techniques.//The Lancet.-1985, N6.-p.1302-
1305.
40. Gil G.M., Vadell N.C., Farbegat M.X. et al. Yield of
diagnostic tests in neoplasms of unknown origin. A retrospective
study.// Rev. Clin. Esp.-1990.-V.186(6),#4.-p.252-258.
41. Giuffri G., Muscarella A. Malignant hypomelanotic
melanoma of mules. A histologic, immunohistochemical and
ultrastructural study of a case with unknown primary site and
widespread metastases. Pathologica. 1995 Feb. 87:1 p.100-104.
42. Gluckman J.L., Robbins K.T., Fried M.P. Cervical metastatic
squamous carcinoma of unknown or occult primary source.//Head-
Neck.-1990.-V.12,N5.-p.440-443.
43. Greco F. A., Hainsworth J.D. Tumors of unknown origin.
// CA. Cancer J. Clin.- 1992.-v.42,#2.-p.96-115.
44. Guarishi A., Keane T.J., Elhacim T. Metastatic inguinal
nodes from an unknown primary neoplasm: a review of 56 cases./
/Cancer.-1987.-v.59,#3.-p.572-577.
45. Guthrie T.H. Treatable carcinoma of unknown origin.//
Amer.J.Med.Sci.- 1989.-v.298,#2-p.74-78.
46. Hainsworth J.D., Greco F. A. Poorly differentiated
carcinoma and poorly differentiated adenocarcinoma of unknown
primary site.// Sem.Oncol.- 1993. – v.20,#6.—p.279-286.
47. Hainsworth J.D., Greco F. A. Treatment of patients with
cancer of unknown primary site.// Imp. Adv.Oncol.-1991.- p.173-190.
48. Hamann G., Meier T., Schimrigk K. Brain metastases as
an initial manifestation of tumor disease.// Nerv.- 1993.-v.64,#2—
p.54-57.
49. Hanna W.M., Kahn H.J. The ultrastructure of metastatic
adenocarcinoma in serous fluids: an aid in identification of primary
site of the neoplasm.//ACTA Cytol.1985.-V.29, N3.p.206-210.
50. Harper C.L., Lofts F.J., Otter M. et al. Prostate- specific
antigen (PSA) immunohistochemistry in the presence of a normal
serum PSA as an aid to diagnosis of adenocarcinoma of unknown
primary site.// Br.J.Hosp.Med.1996 Mar.20-Apr.2 55:6 p.367-368.
51. Haseman M.K., Brown D.W. et al. Radioimmunodetection
of occult carcinoembryonic antigen- produting cancer.//
L.Nucl.Med.- 1992.- v.33,#10.-p.1750-1756.
52. Haskell C.M., Cochran A.J., Barsky S.H. et al. Metastasis
of unknown origin.//Current Problems in Cancer.-1988.-V.12,N1.-
p.1-58.
17